Cyclin-Dependent Kinases to Endocrine Therapy | Adding CDK46 inhibitors to Frontline or 2nd-Line Setting

Cyclin-Dependent Kinases to Endocrine Therapy | Adding CDK46 inhibitors to Frontline or 2nd-Line Setting

moasc

1 year
85 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Rita Sanghvi Mehta, MD, UC Irvine Health, talks about Cyclin-Dependent Kinases to Endocrine Therapy | Adding CDK-46 inhibitors to Frontline or 2nd-Line Setting at MOASC 2018.
Up Next Autoplay